Orthopedics This Week | February 16, 2016

5 ORTHOPEDICS THIS WEEK VOLUME 12, ISSUE 6 | FEBRUARY 16, 2016 to those adjacent levels. That doesn’t happen with Coflex and we’ve proven it with this landmark study.” on. With Coflex, we’re not fusing patients that don’t need to be fused.” Incidence Rates for Lumbar Stenosis “Let me tell you about one of my patients. He was 92 years old. He had severe, painful stenosis at L4-L5. I was very nervous about his expectations because of his age. When we first met I asked him; ‘what are your goals for this surgery?’ He said to me; ‘Doc, I just want to feel like I’m 91 years old again”. Literally the day after his Coflex surgery, he was up and walking with complete resolution of his claudication symptoms. And I asked him ‘how are you feeling now’. He said; “Doc, I feel like I’m 80!” “The other thing I love about this surgery is that no bridges are burned. It is easy to convert to a TLIF or an ALIF if that turns out to be needed later Of all the causes of lower back pain, spinal stenosis with up to Grade 1 spondy, is one of the most common diagnosis leading to spine fusion surgery. It is also a diagnosis which increases sharply with age. Here’s the data: • A Swedish study found that the incidence rate for spinal stenosis as defined as a canal of 11mm or less was 5 per 100,000 inhabitants. • A National Low Back Pain Study recorded that out of 2,374 patients with low back pain, 35% had bone related spinal nerve compression. • Data from the National Ambulatory Medical Care (NAMCS) survey found that 13-14% of patients with low back pain may have spinal stenosis. • The NAMCS data shows the incidence in the U.S. population to be 3.9% of 29,964,894 visits for mechanical back problems. • The Longitudinal Framingham Heart Study found 1% of men and 1.5% of women had vertebral slippage at mean age of 54. Over the next 25 years, 11% of men and 25% of women developed degenerative vertebral slippage. • 250,000-500,000 U.S. residents have symptoms of spinal stenosis Background Coflex had been implanted in more than 10,000 European patients before coming to the U.S. in 2006. The architects behind the American launch of Coflex are the Viscogliosi Allogeneic Morphogenetic Proteins Uniquely processed allograft tissue with high levels of naturally occurring growth factors that play a key role in bone remodeling such as BMP-2, BMP-7, aFGF, and TGF-β1.* Learn more about OsteoAMP at www.OsteoAMP.com * Data on file RPT-000327; data from a single lot of OsteoAMP sponge product. © 2015 Bioventus, LLC. All rights reserved. All trademarks are the exclusive property of Bioventus, LLC. SMK-001507b Active Healing Through Orthobiologics Advertisement ryortho.com | 1-888-749-2153

Orthopedics This Week | February 16, 2016 | Page 5